<qa>  What is the average Lpa group for subjects with normal LpaOpen-label 12-week study, 1g20 mg day of NiacinLaropiprant for 4-weeks followed by 8 additional weeks of 2 g40 mg day. Subjects with normal Lpa will be use as comparative group for the other two groups, so no placebo group is required is this study. 